Potential prognostic biomarkers identified by DNA methylation profiling analysis for patients with lung adenocarcinoma

Oncology Letters
Liankui HanDi Liu

Abstract

Lung adenocarcinoma is frequently occurring type of lung cancer with high metastatic risk. We performed a DNA methylation profiling analysis to identify possible prognostic markers involved in lung adenocarcinoma. DNA methylation profiling data (GSE66386) were downloaded from the Gene Expression Omnibus (GEO) database. Differentially methylated genes were identified using a limma package. GO enrichment analysis was performed to identify vital functions related to differential gene methylation, and pathway analysis was performed to assess the associations between different proteins with regard to regulation of cell function and metabolism. The screening results showed a total of 112,662 differentially methylated genes in lung adenocarcinoma patients compared with those of the normal controls. These CpGs were involved in 16,705 genes. The skeletal system development (P=9.46E-27) and embryonic organ morphogenesis (P=8.67E-24) were found to be involved in lung adenocarcinoma. The cancer (P=3.64E-07), Rap1 signaling (P=9.21E-05) and calcium signaling (P=9.21E-05) pathways constituted the important pathways associated with lung adenocarcinoma. In conclusion, methylatedPTPRF,HOXD3,HOXD13andCACNA1Aare potential markers and may be utili...Continue Reading

References

Jan 1, 1986·Annual Review of Genetics·W J Gehring, Y Hiromi
Jul 31, 2001·International Journal of Cancer. Journal International Du Cancer· Hamada JiT Moriuchi
Jan 28, 2005·Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire·Mélanie J ChagnonMichel L Tremblay
Sep 2, 2005·Nature Reviews. Genetics·Keith D Robertson
Jan 10, 2009·Nature Protocols·Da Wei HuangRichard A Lempicki
Sep 21, 2010·Journal of Translational Medicine·Mónica CastroMarta Sánchez-Carbayo
Aug 31, 2011·World Journal of Gastroenterology : WJG·Yi ShuSheng-Quan Zou
Jan 13, 2012·CA: a Cancer Journal for Clinicians·Rebecca SiegelAhmedin Jemal
Feb 8, 2013·Biomarkers in Medicine·Ioanna BalgkouranidouEvi S Lianidou
May 2, 2013·Cancer Medicine·Matilde L Sánchez-PeñaMauricio Cabrera-Ríos
Mar 25, 2015·Journal of the National Cancer Institute·Dario ConsonniMaria Teresa Landi
Mar 31, 2015·International Journal of Cancer. Journal International Du Cancer·Yan ZhangHermann Brenner
Apr 8, 2015·International Journal of Molecular Medicine·Xudong XuGang Chen
May 6, 2015·Cancer Metastasis Reviews·Aditi MehtaGuillermo Barreto
Aug 21, 2015·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Denis SoulièresBarbara Klughammer
Sep 5, 2015·Scientific Reports·Junseong ParkChulhee Choi
Dec 7, 2016·PLoS Medicine·Jianxin ShiMaria Teresa Landi

❮ Previous
Next ❯

Citations

May 30, 2019·Cancers·Gerardo BottiMonica Cantile

❮ Previous
Next ❯

Software Mentioned

limma

Related Concepts

Related Feeds

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.